PD-L1 expressed on the surface of tumour cells acts as a molecular shield to prevent cytolysis mediated by T cells because PD-1:PD-L1 interaction antagonizes CD28:CD80 co-stimulation36. The gene discussed is CD28; the disease is neoplasm.